Alterations in white matter (WM) may be seen in young relatives at risk and may underlie vulnerability to schizophrenia. We were interested in exploring which of the WM regions were altered in adolescent offspring at familial risk for schizophrenia. We examined structural alterations in the offspring of subjects with schizophrenia or schizoaffective disorder (HR; n = 65; 36 males) and healthy controls (HC; n = 80: 37 males) matched for age and education. MRI images were collected using a GE 1.5 T scanner at the University of Pittsburgh Medical Center. Image processing was done using FreeSurfer (MGH) by an experienced rater blind to clinical data. We used multivariate analysis of covariance, with intracranial volume (p > 0.05) and age as covariates. High Risk offspring had significant reductions in total WM, hemispheric WM and WM within left parietal and left cingulate cortices. Male offspring had more pronounced right hemisphere WM reductions than females.
Introduction
Schizophrenia represents a group of probably etiologically heterogeneous, severe mental disorders the neurobiological underpinnings of which are not yet fully understood (Keshavan et al., 2008a; MacDonald and Schulz, 2009) . Schizophrenia has been thought to result from "disconnectivity" of white matter systems (Friston and Frith, 1995) . It has been proposed that alterations in the white matter connectivity may give rise to the some of the symptoms found in schizophrenia. For example, Crow (1998) suggested that auditory hallucinations could arise from aberrant communication between language centers in the left and right temporal cortices. Hubl and colleagues reported alterations in lateral parts of the arcuate fasciculus in patients with hallucinations (Hubl et al., 2004) . Aberrations in white matter connectivity between distributed systems could also lead to disorders of self-monitoring which in turn could lead to auditory hallucinations (Silbersweig and Stern, 1996, 1998) .
Morphometric studies using ROI methodology have shown that in addition to the gray matter abnormalities, regional and global white matter volumes also have been compromised in schizophrenia (reviewed in Shenton et al., 2001 ). This is supported by several studies using different methodologies such as voxel based Morphometry (Giuliani et al., 2005; Meda et al., 2008) , deformation based Morphometry (Davatzikos, 2005) and ADC (Apparent diffusion coefficient) based Morphometry (Ardekani et al., 2005) . These various methods have shown, albeit with differing results, that white matter volumes in the brain are altered in schizophrenia. A recent review and meta-analysis (Olabi et al., 2011) of 928 patients and 867 controls examining 32 brain regions showed that patients' annual WM volume reduction in several brain regions was −.32% in the frontal, −.32% in the parietal, and −.39% temporal lobes.
While there is growing evidence that schizophrenia subjects show changes in white matter (Bloemen et al., 2010; Kubicki et al., 2007) , there is very little known about whether these alterations are related to underlying liability to the illness. Family history remains one of the strongest etiologic factors in schizophrenia, with an estimated heritability of almost 80% (Mcgrath et al., 2008) . The study of young relatives of patients with schizophrenia therefore offers a unique window into the premorbid liability to the illness (Keshavan et al., 2008b) . The Preclinical (premorbid and prodromal) phase of the illness has been investigated in studies (Lawrie et al., 2001 (Lawrie et al., , 2008 Lymer et al., 2006) that have shown white matter alterations.
Although the evidence for white matter involvement is accumulating, it is unclear whether this involvement is limited to certain regions or whether they are widespread, and whether the familial susceptibility may have a role in the neurodevelopmental aspects of WM. To assess the potential role of WM in disrupted neurodevelopmental processes, we examined volumetric alterations in the white matter of familial HR subjects and Healthy controls. Few studies have Progress in Neuro-Psychopharmacology & Biological Psychiatry 40 (2013) 187-192 
